The effects of melotonin on the anesthetic consumptions and recovery of the negative emotional patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054118

Enrollment

Unknown

Registered

2021-12-09

Start date

2021-12-01

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Negative emotional patients

Interventions

Intervention group:Melatonin 2mg was orally taken every night before operation

Conrol group:Equivalent dose of placebo orally every night before surgery

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with elective unilateral radical breast cancer surgery, aged 18-65 years old; 2. ASA grade I-III, HAMA =7 points.

Exclusion criteria

Exclusion criteria: HAMA score <7, asthma, consumption of caffeinated beverages, use of hydrocortisone or long-term use of analgesics, severe organ dysfunction, history of psychoneurological disorders, allergy to any medication used in the study, and refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
anesthetic consumptions;	—

Secondary

Measure	Time frame
postoperative recovery;	—

Countries

China

Contacts

Public ContactLiu Xuesheng

The First Affiliated Hospital of Anhui Medical University

liuxuesheng@ahmu.edu.cn+86 186 5519 3385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026